Human mesenchymal stem cell (hMSC) proliferation, migration, and differentiation have all been linked to extracellular matrix stiffness, yet the signaling pathway(s) that are necessary for mechanotransduction remain unproven. Vinculin has been implicated as a mechanosensor in vitro, but here we demonstrate its ability to also regulate stem cell behavior, including hMSC differentiation. RNA interference-mediated vinculin knockdown significantly decreased stiffness-induced MyoD, a muscle transcription factor, but not Runx2, an osteoblast transcription factor, and impaired stiffness-mediated migration. A kinase binding accessibility screen predicted a cryptic MAPK1 signaling site in vinculin which could regulate these behaviors. Indeed, reintroduction of vinculin domains into knocked down cells indicated that MAPK1 binding site-containing vinculin constructs were necessary for hMSC expression of MyoD. Vinculin knockdown does not appear to interfere with focal adhesion assembly, significantly alter adhesive properties, or diminish cell traction force generation, indicating that its knockdown only adversely affected MAPK1 signaling. These data provide some of the first evidence that a force-sensitive adhesion protein can regulate stem cell fate. STEM CELLS
INTRODUCTION
Multipotent human mesenchymal stem cells (hMSCs) have been shown to differentiate based on a wide variety of cues, including soluble growth factors and insoluble signals from extracellular matrix (ECM) to which cells bind [1] , namely stiffness [2, 3] , topography [4] , and composition [5] . Modulating cell behavior by ECM stiffness has become increasingly relevant since disease-related stiffness increases [6, 7] may give rise to the mixed outcomes of cell-based therapies [8, 9] . hMSCs cultured in serum-containing media have been shown to differentiate as a function of their substrate stiffness, with their fate matching in vivo tissue stiffness [2] . Myosin contractility has been implicated in regulating these fate choices via RhoA/ROCK in situ [10] , and recent evidence has indicated that the transcriptional regulators Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) are required for hMSCs responding to stiffness [11] . While force transmission and nuclear responses are clearly required, the specific upstream signaling cascade(s) from which they initiate remains unclear for stem cells [12, 13] .
Ample evidence suggests that cells actively measure the strains they impose on their matrix through myosin contraction [14, 15] ; softer matrix deforms more than stiffer matrix does for a given force. Conversely, intracellular proteins connecting matrix and nucleus stretch more with increasing ECM stiffness under the same force [16] . The conversion of this additional protein stretch into a biochemical cue that could induce RhoA/ ROCK activation and lineage specification has been suggested to arise from sensor(s) buried within focal adhesions or the perinuclear cytoskeleton [17, 18] . Since the ECM protein to which stem cells bind can affect whether or not stiffnessinduced fate choice occur [3] , ligation of a specific integrin pair likely initiates this signal and suggests an initial focus on an adhesion-based sensor capable of regulating hMSC fate. Such a mechanism, that is, a "molecular strain gauge" [19] , would respond to increases in actomyosin force generation by unfolding protein domains to a degree corresponding to the force to which they are subjected; newly exposed internal binding sites would therefore initiate new signaling cascades. In vitro data support this strain gauge hypothesis for focal adhesion proteins, which undergo force-induced conformational changes. For example, forced-unfolding of p130Cas reveals phosphorylation sites responsible for recruiting other proteins necessary for assembly of mature adhesions [20] . Talin exposes up to 11 inaccessible vinculin binding sites under force [21] , with vinculin separately binding, unfolding, and functioning differently depending on the amount of force to which it is subjected [22] . Although each adhesion protein may serve as a target for stem cell mechanosensing, a comprehensive list of novel candidates is lacking, and to date, no study has shown this type of sensing mechanism that can regulate stem cell fate.
Here, we show that one candidate signaling mechanism and potential molecular strain gauge, the talin-vinculin-MAPK1 cascade, may be a regulator of stem cell differentiation into a myogenic-like state.
MATERIALS AND METHODS
Cell Culture and Reagents hMSCs were obtained from Lonza, Inc. (Basel, Switzerland, http://www.lonza.com/) and maintained in growth medium (Dulbecco's modified Eagle's medium [DMEM] , 20% fetal bovine serum (FBS), 100 units/ml penicillin, and 100 mg/ml streptomycin) changed every 3 days. Only low passage hMSCs were used for experimental studies. For MAPK1 inhibition, the MAPK inhibitors iodotubercidin and pyrazolylpyrrole, dissolved in dimethyl sulfoxide (DMSO), were used at a final concentration of 0.2 mM and 2 nM, respectively, and added to cells immediately postplating. At 0.2 mM, 5-iodotubercidin is a potent MAPK1 inhibitor, but is not concentrated enough to inhibit phosphorylase kinase (5 mM), casein kinases I and II (0.4 mM and 11 mM, respectively), insulin receptor kinase (3.5 mM), or protein kinase C (0.4 mM). Adenosine kinase is inhibited at very low iodotubercidin concentrations (26 nM) [23] , but has not been previously implicated in myogenesis. At 2 nM, pyrazolylpyrrole has only been shown to inhibit MAPK1 [24] . As siRNA is diluted in culture over time, all mechanical differences in cell populations were assessed while there was still a large difference in cellular vinculin levels, as biophysical metrics are often a function of the current state of the cell, that is, day 2 or as otherwise indicated. Conversely, differentiation experiments took place over the course of 6 days or as otherwise indicated, since differentiation occurs as the integration of cues over time, allowing one to assume that examining the cells over the course of 6 days still reflects the initial RNAi.
Polyacrylamide Hydrogel Fabrication
Acrylamide was polymerized on aminosilanized 12 or 25 mm diameter coverslips. A solution containing the crosslinker N,N 0 methylene-bis-acrylamide, acrylamide, 1/100 volume 10% ammonium persulfate, and 1/1,000 volume of N,N,N 0 ,N 0 -tetramethylethylenediamine was mixed. Two different combinations of acrylamide and bis-acrylamide were used to make 11 and 34 kPa substrates. Approximately 12 or 50 ml of the mixed solution was placed between the aminosilanized coverslip and a chlorosilanized glass slide. Collagen I (100 mg/ml) was chemically crosslinked to the substrates using the photoactivating crosslinker Sulfo-SANPAH (Thermo Fisher Scientific, Inc., Rockford, IL, USA, http://www.thermofisher.com).
siRNA Transfection siRNA oligonucleotides against human vinculin (ON-TARGETplus SMARTpool; Dharmacon) (Thermo Fisher) and a pool of four nontargeting siRNAs control oligonucleotides (Supporting Information Fig. S1B ) (ON-TARGETplus siControl; Dharmacon), diluted in diethylpyrocarbonate-treated (DEPC) water (OmniPure) (EMD Millipore, Billerica, MA, USA, http://www.millipore.com/) and 53 siRNA buffer (Thermo Fisher), were transiently transfected into human hMSCs using Dharmafect (Dharmacon) at a concentration of 50 nM, according to the manufacturers' protocols. Vinculin ON-TARGETplus SMARTpool was a mix consisting of four different siRNAs: Vinculin smart pool duplex 1 (target sequence: CAGCAUUUAUUAAGGUUGA), Vinculin smart pool duplex 2 (target sequence: GCCAAGCAGUGCA CAGAUA), Vinculin smart pool duplex 3 (target sequence: GAGCGAAUCCCAAC-CAUAA), and Vinculin smart pool duplex 4 (target sequence: UGAGAUAAUUCGUGUGUUA). Transfection efficiency was characterized using TYE-563 Transfection Control (IDT, Coralville, IA, USA, www.idtdna.com). After 24 hours of transfection in antibiotic-free media (2% FBS), media were replaced with standard hMSC growth media and cells replated onto appropriate substrates.
Plasmid Construct and Transfection
pEGFP-C1 subcloned with vinculin cDNA of head domain (1-851; labeled as H), pEGFP-C3 subcloned with vinculin cDNA of tail domain (884-1,066; labeled as T), and pEGFP-C1 subcloned with complete vinculin cDNA, which had been originally excised from p1005 with EcoRI and inserted in EcoRI digested pEGFP-C1 (labeled as FL), were obtained from Dr. Susan Craig [25] . Plasmids were purified using QIAGEN Plasmid Midi Kit (Qiagen, Venlo, The Netherlands, www.qiagen.com). hMSCs were transfected in antibiotic-free medium with 1 mg of plasmid precomplexed with 2 ml of Lipofectamine 2000 (Life Technologies, Carlsbad, CA, USA, www.lifetechnologies.com) in 100 ml of DMEM. After 24 hours of transfection in antibiotic-free medium with 2% FBS, medium was replaced with standard hMSC growth medium.
Site-Directed Mutagenesis
Site-directed mutagenesis was performed on plasmid pEGFP-C1 (full length; FL) by PCR using QuikChange II kits (Agilent, Santa Clara, CA, USA, www.agilent.com) to abolish the predicted MAPK1 binding site from ScanSite analysis. The predicted site (amino acids 762-768) was changed from RILLVAK to HVVILGR by the following base pair substitutions on the leading strand: G3674A, A3676G, C3679G, C3682A, G3685C, C3689G, and A3692G. Mutagenic primers were designed using Agilent Technologies' QuikChange Primer Design software: CTTCTGAATTTTCAACCTCCCGTCTTCCCAGAAT CAC-GACGTGGTTCGCTCGTCTAGCAATGCTG and CAGCAT TGCTAGACGAGCGAACCACGTCGTGATTC TGGGAAGACG GGAGGTTGAAAATTCAGAAG. Mutagenesis plasmids were sequenced via Sanger Sequencing by GeneWiz (La Jolla, CA).
Western Blots
Cells were plated at a density of 5,000 cells per square centimeter in 24-well plates. Cell lysates were collected by rinsing samples with cold phosphate-buffered saline (PBS), followed by a 5minute lysis in mRIPA buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 1.5 mM MgCl 2 , 1% Triton X-100, 1% Na-DOC, and 0.1% SDS) with 1 mM EGTA, 1 mM Na 3 VO 4 , 10 mM Na 4 P 2 O 7 , and 1 mM phenylmethanesulfonylfluoride (PMSF). Samples were stored at 280 C until analysis. Cell lysates were run in 10% SDS-PAGE gels at 150 V until proteins were separated and transferred to polyvinylidene fluoride (PVDF) membranes (Bio-Rad, Hercules, CA, USA, www.bio-rad.com) by running at 100 V for 1 hour, 15 minutes in transfer apparatus (Bio-Rad). The membranes were washed in Buffer A (25 mM Tris-HCl, 150 mM NaCl, and 0.1% Tween-20) 1 5% milk overnight at 4 C. The membranes were then incubated with anti-Vinculin, GAPDH, Actin, ERK2, or p-ERK2 (T202 and Y204) for 1 hour, washed with Buffer A 1 milk, and incubated in streptavidin horseradish-peroxidase-conjugated anti-mouse antibodies for 30 minutes at room temperature. Immunoblots were visualized using ECL reagent (Thermo Fisher). All Western blot antibodies were obtained from Abcam (Cambridge, England, www.abcam.com).
Immunoprecipitation
Dithiobis(succinimidyl propionate) (1 mM) (Thermo Scientific), a membrane-permeable amine crosslinker, was used to preserve protein interactions before cell lysis. Protein A-conjugated Magnetic Dynabeads (Life Technologies) were bound to rabbit anti-vinculin antibody for 15 minutes at room temperature, and crosslinked lysates were added for one hour at 4 C. Beads were magnetically captured, lysate decanted, and the beads were then washed with PBS. Protein elution from the beads was performed in 50 mM Glycine, pH 2.8. Supernatants and pellets were prepared for Western blot analysis as described above.
Immunofluorescence hMSC cells were cultured on polyacrylamide (PA) gels, fixed with 3.7% formaldehyde, and permeabilized with 1% Triton X-100. The cells were then stained with primary antibodies against human Vinculin (ab18058 and ab129002, Abcam), human MyoD (MAB3878, Millipore), human pFAK (16-233, Millipore), human Paxillin (ab32084, Abcam), human pERK2 (ab7948, Abcam), human ERK2 (ab7948, Abcam), human GAPDH (ab8245, Abcam), or human CBFa1 (CBFA11-A, Alpha Diagnostics, San Antonio, TX, USA, www.4adi.com). Corresponding secondary antibodies were conjugated to Alexa Fluor 488 (FITC) or Alexa Fluor 647 (Cy5) (Life Technologies). Nuclei were counterstained with Hoechst dye (Sigma-Aldrich, St. Louis, MO, USA, www.sig maaldrich.com), and the actin cytoskeleton was stained with Rhodamine-conjugated Phalloidin (Life Technologies). Alternatively for live/dead assays, cells were treated with paraformaldehyde for a positive control. Calcein and EthD-1 were then incubated with cultures to stain live and dead cells, respectively. Cells were imaged with a Nikon Eclipse Ti-S inverted fluorescence microscope equipped with a BD Carv II camera. Images were processed and analyzed with ImageJ software (NIH, Washington, DC, USA, www.nih.gov). Image thresholding for display purposes was consistent for each channel and within a given experiment.
Alkaline Phosphatase Staining
Cells in the indicate conditions were fixed in 3.7% formaldehyde, rinse in water, and incubated in a water/Naphthol phosphate/fast red violet solution (1:1:2 ratio) for 30 minutes according to the manufacturer's instructions (Millipore). Cells were rinsed and imaged in bright-field as with a Nikon Eclipse Ti-S inverted fluorescence microscope equipped with a BD Carv II camera.
Quantitative PCR
mRNA was obtained using a previously published protocol [26] . Briefly, cells were lysed in trizol, separated with chloroform, and precipitated by isopropanol. The samples were centrifuged, the supernatant removed, and the pellet washed with 75% ethanol. After removing the supernatant, samples were resuspended in DEPC water. Reverse transcription polymerase chain reaction was performed at 37 C for 60 minutes, followed by 99 C for 5 minutes, followed by 5 C for 5 minutes. Samples containing 2 mg of cDNA were added to a mastermix containing of 10 mM dNTP (Roche Basel, Switzerland, www.roche.com), 100 mM dithiothreitol (DTT) (Life Technologies), 53 First Strand Buffer (Invitrogen), 50 mM Random Hexamers (Qiagen), 200 U/ml Reverse Transcriptase (Life Technologies), and DEPC H 2 O. qPCR was then performed using an 7900HT Fast Real-Time PCR machine (Applied Biosystems, Foster City, CA, USA, www.appliedbio systems.com). Primers coding for Pax3, Pax7, MyoD, Mrf4, Myf5, GAPDH, and the vinculin constructs H, T, and FL are listed in Supporting Information Table S2 . For differentiation markers, data are shown relative to the undifferentiated cells. Data were analyzed using a previously described method [27] .
Traction Force Microscopy
Cells were plated at 10 2 cells per square centimeter onto 2 kPa 25-mm diameter PA hydrogels to ensure that only individual cells spaced far apart were present so that traction fields would not overlap. Fluorescent microspheres (0.2-mm diameter) (Fluo-Spheres, Life Technologies) were added to hydrogels in suspension, at a ratio of 30 ml of beads for every 1 ml PA solution.
Hydrogels (2 kPa) were selected due to their optimal deformation levels in response to cellular traction, allowing for an increased resolution of traction force as compared to 11 kPa; tractions scale linearly with stiffness so results from softer matrix should reflect the same trends for stiffer substrates. In order to prevent bead agglomeration, PA/bead suspensions were vortexed, sonicated for 15 minutes in a water bath, and then centrifuged for 5 minutes at 12,000 RPM. The aqueous phase of the suspension was then transferred into a fresh eppendorf tube for polymerization initiation. After 2 days, gels were transferred to a 25 mm sealed coverslip dish and placed in a 160 3 110 mm 2 sealed glass chamber insert (ASI Imaging) for imaging. After identifying a candidate cell in bright-field at 603, the absolute stage position was stored in the computer. A 50 image, 0.4 mm incremented, 20 mm total Z-stack was obtained using the confocal microscope and the automated stage control. After imaging other cells in the same way, warm 2.5% Trypsin was added to the coverslip dish to detach the cells. Using the stored position data, confocal Z-stacks of equal dimensions were taken at each previously imaged location. These stacks were then used to obtain measurements for the total strain energy generated by the cell, broken down into tangential and normal strain as well as total substrate deformation (Supporting Information 
Cell Spinning Assay
Cell spinning assay was performed as described previously [28] . Briefly, knockdown and wild-type cells (50,000 cells per gel) were plated onto 25 mm collagen coated coverslips. After 24 hours, coverslips were placed into the spinning apparatus and subjected to 4,000 RPM spin for 5 minutes, followed immediately by fixation with 3.7% paraformaldehyde. Cells were then stained with DAPI, and using the ScanSlide function of the automated stage (MetaMorph, Molecular Devices, Sunnyvale, CA, USA, www.moleculardevices.com), the entire coverslip was imaged. Images were then analyzed in MATLAB using unpublished code developed by Alexander Fuhrmann, in which the image is thresholded and the number of nuclei at a given radius "shell" is plotted against radius (Supporting Information Fig. S7 ).
Statistics
All experiments were performed in triplicate with the number of cells analyzed per condition as indicated. Error bars are shown as SD. Significance was assessed by ANOVA at a significance threshold of p < .05 or lower as indicated. Values between 0.1 and 0.05 are noted as well. For instances where data are not significantly different, N.S. is stated.
RESULTS

Vinculin Knockdown Adversely Effects hMSC Fate and Behavior
To ascertain vinculin's role in mechanotransduction, hMSC vinculin was transiently knocked down with siRNA up to 80% (Supporting Information Fig. S1A ), reducing both cytoplasmic and focal adhesion-localized vinculin (Fig. 1A, top) . Firm, 11 kPa matrices induce peak expression of early myogenic transcription factors, for example, MyoD [2] , after 4 days in culture with a subsequent decrease in expression consistent sequential activation of myogenic factors in muscle [26, 29] . However, vinculin knockdown hMSCs on the same matrix showed significantly less MyoD (Fig. 1A, bottom ). Scrambled siRNA showed no effect on MyoD expression (Supporting Information Fig. S1B ), whereas no MyoD was produced on nonpermissive, stiff matrix independent of vinculin ( Fig. 1B) . Quantitative PCR of hMSCs after 4 days in Holle, Tang, Vijayraghavan et al.
culture, when MyoD expression was strongest, showed that they express significantly more myogenic specification and commitment markers relative to undifferentiated cells; this is consistent with commitment and initial differentiation into a myogenic lineage [30] . Vinculin knockdown cells had significantly reduced expression of the same transcription factors relative to undifferentiated control cells (Fig. 1C ). Vinculin knockdown was transient (Supporting Information Fig. S1A ), so we also determined if cells could become myogenic once vinculin expression recovered. Indeed, MyoD expression, which was repressed at 4 days in culture in vinculin knockdown hMSCs relative to wild-type cells, was induced in hMSCs after 12 days (Supporting Information Fig. S1C ). To determine whether vinculin also affected osteogenic induction on stiff matrices, hMSCs were plated onto 34 kPa matrix but osteogenic commitment was found to be insensitive to vinculin knockdown as observed by expression of CBFa1 (Supporting Information Fig. S2A ) and alkaline phosphatase staining (Supporting Information Fig. S2B ), indicating that vinculin is at least necessary to sense matrix stiffness but only for a specific differentiation program.
These matrices provide constant stiffness to hMSCs, but rarely does this occur in vivo. Spatial stiffness variations can induce migration or "durotaxis" from nonpermissive to permissive matrix. Durotaxis often precedes hMSCs differentiation [31] but may use the same sensory machinery. To assess vinculin's involvement in sensing spatial stiffness changes, hMSCs were cultured on matrix containing alternat-ing "stripes" of soft and firm matrix to create a steep stiffness gradient at their interface (Fig. 1D, 1D 0 ). Vinculin knockdown hMSCs exhibited delayed durotaxis, while within 24 hours, untreated cells preferentially accumulated on myogenicinducing firm matrix, indicating robust durotaxis (Fig. 1D 00 ) . Durotactic changes were not the result of cell death [32] or altered cell migration as knockdown and untreated hMSCs on static 1 kPa and 11 kPa substrates had similar migration speed (Supporting Information Fig. S3A ) and did not display any directionally biased migration (Supporting Information Fig. S3B ). Thus, vinculin would appear to be required for sensing stiffness and converting it into an active cell response such as directed migration.
Bioinformatic Analysis of Vinculin's Mechanosensing Potential
A force-sensitive unfolding event could change the accessibility of a cryptic kinase site, and thus kinase binding domains and their accessibilities were determined using Scansite [33] for 47 proteins either related to the adhesome or previously implicated in mechanotransduction [34] . This analysis revealed 465 predicted binding sites, which were plotted as a function of their surface accessibility ( Fig. 2A ). Binding sites for MAPK1, also known as ERK2, were found both extremely often (39 times; the most of any binding partner) and were the most inaccessible binding site on average (accessibility value of 0.535; Supporting Information Table  S1 ). Vinculin, which has an autoinhibited conformation [35] until it binds to talin and undergoes a force-induced conformational change [21] , had three predicted kinase binding sites, one of which is a very inaccessible MAPK1 binding site ( Fig. 2A, purple ; accessibility value of 0.164). This site occurs near vinculin's hinge region and is flanked by structural protein binding sites, implying that a force-induced conformational change in vinculin could occur from relative changes between protein positions; such change may then alter MAPK1 binding site accessibility (Fig. 2B ). Vinculin and phospho-MAPK1 were also found to colocalize in focal adhesions in hMSC after 48 hours on 11 kPa matrix (Fig.  2C ). Cell-generated traction force scales with matrix stiffness [16] , and thus at an optimal force in hMSCs on 11 kPa matrix, cryptic regions within talin may become accessible via talin unfolding and permit vinculin binding [21] that enhances MAPK1 accessibility. To further substantiate possible vinculin-MAPK1 interaction, vinculin was immunoprecipitated, and MAPK1 and phosphorylated MAPK1 were detected in pulled-down samples (Fig. 2D, top) . Normalized phosphorylated MAPK also appeared matrix stiffnessdependent (Fig. 2D, bottom) .
MAPK1-Binding Vinculin Domains Rescue Vinculin-Dependent Myogenesis
Despite vinculin's involvement in myogenesis, the specific mechano-signaling pathway(s) regulating stem cell commitment remain unconfirmed. Based on Scansite predictions, constructs expressing green fluorescent protein (GFP) and chicken vinculin domains containing or lacking the MAPK1 binding site, that is, head or tail domains [36] , respectively, were selectively added back to knockdown hMSCs (Fig. 3A 0 ,  Supporting Information Fig. S4A ). In hMSCs grown on firm matrices for 4 days, wild-type cells as well as cells with full length and head domain vinculin added back began to express MyoD at levels similar to wild-type (Fig. 3A) . Tail domain alone was insufficient to completely rescue MyoD expression ( Fig. 3B) , indicating that the head domain of vinculin may be necessary for myogenesis. To assess the necessity of the predicted MAPK1 binding site within the head domain for stiffness-based myogenesis, site-directed mutagenesis against the predicted MAPK1 binding domain was performed and confirmed by Sanger Sequencing (Fig. 3A 0 , Supporting Information Fig. S4B ). hMSCs receiving this FL-Mut construct via transfection were unable to express MyoD at wild-type levels after 4 days (Fig. 3C, 3D ). Moreover, Myf5 was detected by immunofluorescence after 4 days in wild-type hMSCs and cells receiving FL constructs, but not FL-Mut constructs (Fig.  3E) . For all cases, GFP expression, which confirmed vinculin re-expression in knockdown cells, was observed (Fig. 3A, 3C , 3E, open arrowheads).
Phosphorylated MAPK1 was found to be less abundant on softer matrices as well as in vinculin knockdown cells on stiffer matrices (Fig. 4A) , indicating that its function may correlate with vinculin expression. MAPK1 is a stage-specific positive regulator of early myogenesis [37] [38] [39] . To substantiate that MAPK1 has the same capacity for stiffness-induced hMSC myogenesis, the MAPK1 inhibitor 5-iodotubercidin was selectively added to cells to ablate MAPK1 function and found to downregulate its expression ( Fig. 4B ). Loss of global MAPK1 function from treatment with 5-iodotubercidin or another highly selective MAPK1 inhibitor, pyrazolylpyrrole, resulted in reduced MyoD expression, similar to the reduction found in vinculin knockdown cells. Combining vinculin knockdown with iodotubercidin did not further reduce MyoD expression although the combination of vinculin knockdown and pyrazolylpyrrole did (Fig. 4C ). Inhibitors did not dramatically alter cell morphology (Supporting Information Fig.  S5A ), perturb vinculin expression (Supporting Information Fig. S5B ) or assembly (Supporting Information Fig. S5C ), and they did not alter cell area (Supporting Information Fig.  S5D ), implying that only signaling and not focal adhesions were perturbed. Pyrazolylpyrrole treatment with or without vinculin knockdown also interfered with durotaxis (Supporting Information Fig. S5E ).
Vinculin Knockdown Does Not Alter Focal Adhesion Structure or Function
To implicate the role of vinculin only as a signaling protein in this context, cell behavior and focal adhesion structure and function as an "inside-out" force transducer must remain unperturbed; otherwise, changes in cell behavior or focal adhesion superstructure could have induced some of the observations here. Vinculin knockdown was not found to significantly affect cell proliferation, cell area, cell morphology, the number of focal adhesions per cell, or the total focal adhesion area per cell (Supporting Information Fig. S6A-S6D ). Vinculin knockdown also did not significantly affect cell viability, as measured by Western blots for housekeeper proteins GAPDH and b-actin (Fig. 5Ai ) and a live/dead assay (Supporting Information Fig. S6E ). Focal adhesion structure, distribution, and morphology also appeared unchanged as well as composition as assessed by phospho-focal adhesion kinase (FAK) expression ( Fig. 5Aii, 5Aiii ). Focal adhesions must facilitate cell adhesion and the transmission of actomyosin contractions to the adjacent matrix and cells, and to ensure that their functions were not perturbed, two mechanical assays were used. First, a spinning disc assay was used to measure adhesion strength by exerting radially dependent shear and monitoring cell adhesion as a function of shear (Supporting Information Fig. S7A ). The average adhesion strength is defined by the shear required to detach 50% of the cells, that is, s 50 , permitting quantitative comparisons [40] (Supporting Information Fig. S7B, S7C ). Vinculin knockdown did not significantly alter s 50 relative to untreated cells (Fig. 5B) , with the shear required to detach cells being well above physiolog-ical levels [41] . Focal adhesions are also responsible for transmitting cell-generated traction forces, and traction force microscopy can be used to monitor how a cell pulls against its matrix, both normal and tangential to the matrix surface (J.C. Del Alamo, R Meili, B Alonso-Latorre et al., manuscript submitted for publication) [42] . Matrix deformation (Fig. 5C , left) was used to compute the energy required for each deformation ( Fig. 5C, right) . Integration over each cell yields the total strain energy, or work done by the cell to deform the matrix, which can be resolved into normal and tangential contributions (Supporting Information Fig. S8A-S8C ). No difference was observed between strain energy contributions (Supporting Information Fig. S8D, S8E ) or total strain energy for wild-type and vinculin knockdown hMSCs (Fig. 5D ).
DISCUSSION
Recent discussion has suggested a general link between ECM and the nucleus [17, 18] , and even in vitro and in situ reports identify some potential nuclear targets including YAP and TAZ [11] and a focal adhesion sensor, for example, vinculin [21, 22] , which could lend themselves to this process. While not previously connected in the context of stem cell differentiation, in this study, we attempted to link the role of an in situ change in vinculin with myogenesis observed specifically because of the mechanical environment provided by the surrounding ECM. We document a class of potential focal adhesion-based mechanosensing proteins with internal predicted kinase sites. In the talin-vinculin complex, changes to kinase-binding site accessibility could occur on myogenically favorable substrates. Indeed, when vinculin was knocked down in hMSCs, impaired myogenesis and durotaxis were observed. Rescue experiments identified the distal portion of the head domain, where a cryptic MAPK1 binding site is predicted, to be critical for myogenesis; MAPK1 inhibition produces a similar effect, although the combination with vinculin knockdown was less effective for both myogenesis and durotaxis perhaps via RISC inhibition [43] . Consistent with our hypothesis here, hMSCs appear to exhibit large strains in matrix that induces myogenesis, for example, 11 kPa [44] , which aligns stem cells' cytoskeleton [45] and could stretch vinculin in situ and expose cryptic signaling sites.
Elucidation of Novel Mechano-Sensors
Recently, there has been a significant effort to expand our understanding of how cells sense matrix stiffness. Nuclear translocation of transcription factors YAP and TAZ [11] has been implicated in regulating shape-dependent endothelial cell survival as YAP/TAZ expression correlated with stiffnessdependent expression of mammary epithelial genes. An alternative approach has been to screen signaling pathways involved in a behavior, for example, fibroblast focal adhesion size, cell polarization, and traction force. In this case, protein tyrosine kinase knockdown identified kinases involved in enhancing, suppressing, or not affecting stiffness-sensing [46] .
Both approaches produce a wealth of knowledge but do not indicate what or how a biophysical signal-like stiffness is converted into a biochemical signal in the cell. F€ orster resonance energy transfer (FRET)-based sensors can accurately measure protein stretching and mechanical activation [22, 47] , but have limited throughput for screening. Cells contract and change the conformations of cytoskeletal proteins differently as a function of matrix stiffness [16] ; Scansite analysis indicated that the talin-vinculin complex may have this capability in situ. This lead to the hypothesis that vinculin may either monotonically or biphasically increase MAPK1 signaling, with stretch leading to differentiation. Interestingly enough, differentiation did not appear to be monotonically increasing with additional stretch, as osteogenic differentiation was not influenced by vinculin knockdown.
The Many Roles of Vinculin in Focal Adhesions
Our results indicate that there are not significant changes in the structural, adhesive, or mechanical functions of adhesion when vinculin is dramatically reduced but not absent in hMSCs. Reintroduction of vinculin domains containing the MAPK site, for example, full length and head, also restored MyoD expression to wild-type levels, whereas constructs specifically lacking it did not, for example, FL-Mut. Tail only constructs, which lack the MAPK site, partially rescued expression and suggest possible MAPK-independent alternatives. Yet additional kinase binding sites on vinculin's tail (Supporting Information Table S1 ) and its ability to bind paxillin and actin could allow soluble vinculin tail to preferentially induce other signaling pathways or alter focal adhesion composition in such a way as to affect MyoD expression.
Vinculin acting largely as a signaling protein also is in contrast to previous findings with senescent cells, where 3T3 fibroblasts displayed a 20% decrease in adhesion strength as a result of siRNA-induced vinculin knockdown [48] . Tractions and invasion assays are also lower in vinculin-null fibroblasts [49, 50] and vinculin-null carcinoma cells had decreased spreading versus their wild-type counterparts [51] . One could argue that there could be a signaling threshold so that null and knockdown cells could have dramatically different signaling capabilities, but differences nonetheless raise the question of what accounts for this discrepancy. First, vinculin's functionality may depend on cell state: in terminally differentiated cells, vinculin may play an increasingly structural role versus only a signaling role in hMSCs. Stem cell adhesions are extremely sensitive to ECM stiffness and composition compared to senescent cells [2, 5, 52, 53] , and vinculin may act in a more signaling capacity to compensate. Second, serum concentration has been shown to modulate these responses [48] . hMSCs prefer significantly higher serum concentration versus fibroblasts, so differential mechanical effects in fibroblasts but not in hMSCs may be the result of compensatory adhesive mechanisms at high serum concentration. Even if there is some structural contribution in hMSCs that was not detected by the assays here, these data are supportive of a significant role for vinculin in mechanically directed myogenesis as described below.
Mechano-Sensing Myogenic Signaling Pathways
While regulatory molecules, including many small Rho GTPases, have been implicated in regulating cell behavior [54] , the exact pathways between molecules, gene expression, and behavior remain somewhat disconnected. The data here substantiate a link between vinculin and MAPK1 in myogenic regulation, which can be regulated by more or less force generated via changing matrix stiffness or blocked via addition of Figure 6 . A model of myogenic mechano-sensing. As actomyosin contraction increases the amount of force applied to focal adhesions, talin and vinculin associate and likely undergo a conformational change to activate vinculin. This permits the latter portion of vinculin's head domain, which has predicted MAPK1 binding, to regulate mechanically induced myogenesis while not altering other structural, adhesive, or mechanical function of the human mesenchymal stem cells. Impaired MAPK1 function blocks this process, and may alter the function of its nuclear targets. small molecules such as pyrazolylpyrrole or iodotubercidin. The proposed mechanism is summarized in Figure 6 and likely terminates in the nucleus with transcriptional regulation from MyoD and other myogenic markers measured here. MAPK1's role in this pathway likely involves its nuclear substrates, including the nuclear envelope protein Nesprin-2 [55] , which has been shown to play a role in muscle differentiation [56] . Thus, MAPK1 could become active upon vinculin binding, act on proteins including Nesprin, and result in MyoD expression. This model of MAPK-regulated MyoD expression has been recently described in satellite cell activation [57] and appears to corroborate our findings where a specific level of strain energy, 1.5 pJ, produces optimal MAPK activation and subsequent induction of myogenic differentiation; too much or too little strain energy may not provide sufficient signaling. MAPK1's modifiers provide further credence for this mechanosensitive model; p38 MAPK and MKK6 function is required not just for MAPK1 activation but also for MyoD expression [58] . Myogenic MAPK1 substrates also include p90 ribosomal S6 kinase [59] and Est1 [60] , but their function as substrates may be context specific as PPARc, an adipogenic marker, is also a MAPK1 substrate in preadipocytes [61] . This begs the question that for hMSCs, which presumably lack such context-dependent function, what downstream signaling cascade is most appropriate? Jaiswal et al. have shown that chemically induced osteogenesis involves MAPK1, suggesting a monotonically increasing signal [62] . However, in the context of stiffness-induced differentiation, our data indicate that MAPK1 function is stiffness sensitive and acts via vinculin on myogenic targets including MyoD, not on osteogenic targets such as Runx2. Although induction methods may give rise to these signaling differences, our observations point to the need for additional exploration of how MAPK1 substrates compete for activation in a multipotent or pluripotent cells.
CONCLUSION
Taken together, these data provide the first demonstration that a focal adhesion protein, for example, vinculin, can act as a regulator of matrix stiffness-induced hMSC differentiation. Moreover, regulation is signaling dependent and not influenced by structural or functional changes in adhesions as a result of the loss of vinculin. The identification of other cryptic signaling sites in focal adhesions may lead to the characterization of new mechano-regulation mechanisms.
